DrugRisk Update: New Competition for NuvaRing as Blood Clot Lawsuits Increase

Share Article

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

News Image
Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

The prescription resource center DrugRisk.com is alerting women who have used the contraceptive NuvaRing of new information to the site showing the number of claims for blood clot injuries has increased, just as the vaginal ring gets competition from a new device.

“DrugRisk’s mission is to improve patient safety by providing the public with the latest drug warnings, recalls, studies and litigation news. In many cases visitors use information on lawsuits to see if others are experiencing similar problems and whether they have options,” explains DrugRisk representative Ryan Mayer.

The resource center has added information showing that a new contraceptive device from Bayer, called Skyla, recently gained FDA approval. The IUD is designed to provide pregnancy prevention for up to 3 years, similar to NuvaRing.*

DrugRisk previously added warnings from experts that vaginal rings like NuvaRing may be linked to higher blood clot risks than traditional birth control pills. At this time there is no official NuvaRing recall.

The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.

Now, DrugRisk has learned that the number of NuvaRing blood clot lawsuits has risen by nearly 5% to 1076 from the last report, according to the U.S. Judicial Panel on MultiDistrict Litigation.**
Due to the number of claims, cases have been consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, NuvaRing side effects and litigation news related to the device and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*press.healthcare.bayer.com/en/press/news-details-page.php/14868/2013-0001
**jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-November-2012.pdf

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website